Идея: Идея 19

  • Автор: Ткаченко Юрий Александрович
  • Добавлен: 20.04.2017

SMA®T Arthritis is a new patented easy-to-use home medical solution which includes a sensor and an application for iOS and Android smartphones. It is designed to provide objective medical monitoring for successful treatment of knee arthritis. SMA®T Arthritis can be a key element of knee arthritis ownership business model for pharmaceutical or medical devices enterprise. When joint inflammation is present, there is always an increase in the local temperature of skin. It’s a well-known fact that temperatures increase (thus inflammation) often precedes a pain sensation in a knee joint. SMA®T Arthritis enables a patient with the ability to detect inflammation growth earlier thus preventing a pain syndrome with applying a treatment for his knee upfront. SMA®T Arthritis is capable of proactive reminding a user to assess his knee joint on daily basis providing actionable guidance towards persistent pain relief. SMA®T Arthritis converts virtuality into reality. Your marketing campaign will look very strong and persuasive resulting in a significantly higher investment return rate. Just imagine that every single buyer of your product can see a hot colorful spot on his painful knee, every day. Exactly like advertised. SMA®T Arthritis have designed and patented a method, a device for iPhone\Android and software, which visualizes the inflamed area. The solution fully satisfies and meets expectations of the customers who saw the advertisement and a familiar with the concept of "painful spot". Huge budgets spent by manufacturers of pain killers and NSAIDs on promotion can be now leveraged by your campaign thus improving efficiency of your marketing. Comprehensive visual images help users answer the following questions: • Is my treatment efficient enough? • Which habits help my knee arthritis? • Which is the best treatment for me? • Which physical exercises can improve the situation and how intense they should be? • What is the best knee arthritis friendly diet for me? • Where should I rub my anti-inflammatory gel more and does it actually help me? Before SMA®T Arthritis, knee arthritis sufferers were relying on inaccurate subjective pain sensations when it came to managing their knee joint inflammation. Today we provide an objective way of inflammation tracking therefore supporting effective decisions made by a doctor or a patient himself/herself. In addition to that, SMA®T Arthritis is valuable source of the information to support doctors’ decision process and is highly appraised by professionals including telehealth companies. SMA®T Arthritis is very similar to glucometer and blood pressure monitors by usage scenarios and values provided, but it is intended for knee arthritis monitoring. It solves a similar range of problems. The technology and invention have umbrella patent protection which covers the method in the major markets including US, JP, CN, KR, GB, FR, DE, IT, PL, SE, ES, IL, RU. SMA®T Arthritis consists of: • A standard non-patented medical IR thermometer attached to a smartphone • An iOS or Android application SMA®T Arthritis is not aimed for diagnostics. It is uniquely designed to monitor knee arthritis for those who have already been diagnosed with knee arthritis. The product can be used by patients at home, without a doctor’s assistance.

Описание инновационной составляющей идеи SMA®T Arthritis consists of: A standard non-patented medical IR thermometer attached to a smartphone An iOS or Android application SMA®T Arthritis is not aimed for diagnostics. It is uniquely designed to monitor knee arthritis for those who have already been diagnosed with knee arthritis. The product can be used by patients at home, without a doctor’s assistance. The technology and invention have umbrella patent protection which covers the method in the major markets including US, JP, CN, KR, GB, FR, DE, IT, PL, SE, ES, IL, RU.
Стадия идеи, стартапа Negotiations on the sale of the project IP.
Вложенные средства $600K
Требуемый объем инвестиций $17.5mln.
Схема коммерциализации С привлечением заемного капитала (кредит)
Документы: разрешительная документация, наличие патента, товарного знака USA patent US 9498166 Japanese Patent JP 5890841 EP patent EP 2591718 (validated in France, Germany, Great Britain, Italy, Poland, Spain, and Sweden). Chinese Patent CN 103188991 Korean Patent KR 101651721 Israel Patent IL 225890 Russian Patent 2452925 Russian Patent 2487341 Russian Patent 2545423 International trademark registration No. 1214070 validated in Korean (registration No.1214070), Europe (registration No.1214070), USA (registration No. 4762477) Russian Trademark 583565 Russian Trademark 508621
Аналитика рынка Opportunities for pharmaceutical manufacturers (NSAIDs) Have you seen Nurofen ads? With SMA®T Arthritis your customers can see the results from taking your pills or applying your gel themselves almost immediately. We believe that a package or ads with the colorful images will drive sales of your product and significantly improve loyalty to your brand as it objectively proves that your NSAID is efficient personally for a patient. It can also increase volume of gel consumed by a customer as SMA®T Arthritis can be used to pinpoint an area of a maximum inflammation in order to apply more gel into the identified area. NSAIDs market size reached $11.4 bln in 2014. Moreover the National Institute for Health and Care Excellence (NICE) gives a clear guidance to healthcare professionals to prescribe topical NSAIDs in the first instance for joint pain associated with osteoarthritis, in preference to oral NSAIDs, owing to concerns over systemic side effects caused by the long term use of oral NSAIDs. As a result, the US topical NSAIDs market has grown to $1bln. The market of NSAIDs (gels and\or pills) is very competitive. SMA®T Arthritis can be used by a pharmaceutical company to attract new customers and increase its market share. We believe that colorful and clear demonstration of inflammation reduction to a customer should significantly drive sales of your product. Just imagine your product demonstrates a colorful visualization of the results of the treatment with your NSAID. One may also choose to bundle their anti-inflammatory pills\gels with SMA®T Arthritis as mass production cost for the sensor is as low as ~$4. One of the feasible options is to embed SMA®T Arthritis into a brand product line with a sample slogan "The only NSAIDs with the proven personalized efficacy on the market". This will create the distinguishable advantage over other competitors for the brand through trust thus resulting in higher sales and loyalty. The product bundle will become a killer for competing products. SMA®T Arthritis provides a unique opportunity to increase sales through increased customer confidence in a gel efficacy and added value. The product can colorize and pinpoint an area on a knee surface which corresponds to a higher inflammation. A user can apply larger amounts of gels onto that area thus improving effect of the medicine. What would you say if your gel is bundled with the solution helping a user to identify an area to apply it in higher volumes and reduce the pain faster? SMA®T Arthritis objectively shows that NSAIDs use reduces temperature in the knee joint, often before pain relief. However, commonly used dosage is insufficient for achieving stable anti-inflammatory and pain relieving effect, so almost all people suffering from knee arthritis will consume more NSAIDs when using SMA®T Arthritis (without exceeding the maximum daily dosage specified in the instructions). Costs Net profit from a sale of one SMA®T Arthritis is ~$35. Manufacturing costs of IR-thermometer currently is $9 and it will go down to $4 for mass production. The validated sale price of the finished product is $49 per unit. There is a large selection of IR-thermometer manufacturers on the market. The technology doesn't enforce any specific requirement on the thermometers apart from an easy to use design in the knee arthritis application. There are numerous manufacturers of medical thermometers available on the market. An acquirer can choose the best one on the competition basis. If the device redesign is required an engineering company can execute the job for as low as $50K.
Предложить идею База идей